Reaction
Uterine Enlargement reporting signals
As of the last recalculation, Uterine Enlargement appears in 785 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is BLEOMYCIN SULFATE (PRR 91.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bleomycin Sulfate | 34 | 91.2 | 91.5 |
| Copper | 64 | 42.8 | 42.8 |
| Misoprostol | 7 | 19.2 | 19.2 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 15 | 17.3 | 17.3 |
| Levonorgestrel | 110 | 16.7 | 16.7 |
| Etonogestrel And Ethinyl Estradiol | 13 | 15.8 | 15.8 |
| Etoposide | 35 | 13.2 | 13.2 |
| Pegfilgrastim | 37 | 10.4 | 10.4 |
| Leuprolide Acetate | 26 | 9.2 | 9.2 |
| Etonogestrel | 6 | 3.4 | 3.4 |